Irani, Jacques <br/><br/>
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.  [electronic resource] 

 -  The Lancet. Oncology  Feb 2010 
 - 147-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(09)70338-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Androgen Antagonists--adverse effects<br/>Autonomic Agents--therapeutic use<br/>Cyclohexanols--therapeutic use<br/>Cyproterone Acetate--therapeutic use<br/>Double-Blind Method<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Hot Flashes--chemically induced<br/>Humans<br/>Male<br/>Medroxyprogesterone Acetate--therapeutic use<br/>Prospective Studies<br/>Prostatic Neoplasms--drug therapy<br/>Treatment Outcome<br/>Venlafaxine Hydrochloride